Elsevier, The Lancet, Volume 399, 12 February 2022
Background: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen–drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. Methods: We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen–drug combinations in 204 countries and territories in 2019.
The 2021 China report of the Lancet Countdown on health and climate change: seizing the window of opportunity
The Lancet Public Health, Volume 6, December 2021
A Health Policy paper on the threats posed by climate change to population health in China, in the context of SDGs 3, 9, and 13, focusing specifically on how the country can manage these risks to lead a green recovery.
Elsevier, The Lancet Planetary Health, Volume 5, December 2021
Systems thinking in COVID-19 recovery is urgently needed to deliver sustainable development for women and girls
In low-income and middle-income countries, such as those in sub-Saharan Africa and Latin America, the COVID-19 pandemic has had substantial implications for women's wellbeing. Policy responses to the COVID-19 pandemic have highlighted the gendered aspect of pandemics; however, addressing the gendered implications of the COVID-19 pandemic comprehensively and effectively requires a planetary health perspective that embraces systems thinking to inequalities.
Elsevier, Annals of Emergency Medicine, Volume 78, November 2021
The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that “Racism is a Public Health Crisis.” Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequities.
Elsevier, The Lancet, Volume 398, 6 November 2021
The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world
Elsevier, The Lancet Planetary Health, Volume 5, November 2021
The ongoing COVID-19 pandemic, caused by zoonotic SARS-CoV-2, has important links to biodiversity loss and ecosystem health. These links range from anthropogenic activities driving zoonotic disease emergence and extend to the pandemic affecting biodiversity conservation, environmental policy, ecosystem services, and multiple conservation facets. Crucially, such effects can exacerbate the initial drivers, resulting in feedback loops that are likely to promote future zoonotic disease outbreaks.
Elsevier, The Lancet, Volume 398, 30 October 2021
The Lancet Public Health, Volume 6, September 2021
This Comment supports SDGs 3 and 10 by discussing the UK's reliance on digital technologies during the COVID-19 pandemic. Although a digital-first policy aims to reduce health inequalities, challenges such as low usage of the internet and low uptake of digital COVID-19 technologies among older, minority ethnic groups, could mean that the strategy instead reinforces the unequal effects of COVID-19.
Vaccine, Volume 39, 23 August 2021
Hepatitis B (HB) vaccination plays a significant role in controlling HBV infection. Different immune mechanisms govern anti-HBs acquisition, titer, and maintenance. Host pre-vaccination immunological status could be targeted for vaccine efficacy.
Elsevier, The Lancet Public Health, Volume 6, July 2021
Disruptions to cancer screening services have been experienced in most settings as a consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by temporarily expanding capacity; however, in practice, this is often not possible. We aim to inform the deliberations of decision makers in high-income settings regarding their cervical cancer screening policy response. We caution against performance measures that rely solely on restoring testing volumes to pre-pandemic levels because they will be less effective at mitigating excess cancer diagnoses than will targeted measures.